Schroder Investment Management Group raised its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 8.8% in the fourth quarter, Holdings Channel reports. The fund owned 1,646,589 shares of the biopharmaceutical company’s stock after buying an additional 132,679 shares during the period. Schroder Investment Management Group’s holdings in Gilead Sciences were worth $133,390,000 as […]
Cibc World Markets Corp cut its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 11.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 453,247 shares of the biopharmaceutical company’s stock after selling 58,865 shares during the quarter. Cibc World Markets Corp’s […]
Capital International Sarl lifted its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 19.4% in the fourth quarter, HoldingsChannel reports. The firm owned 69,414 shares of the biopharmaceutical company’s stock after buying an additional 11,255 shares during the period. Capital International Sarl’s holdings in Gilead Sciences were worth $5,623,000 at the end of […]
Tower Research Capital LLC TRC boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 208.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 201,060 shares of the biopharmaceutical company’s stock after acquiring an additional 135,782 shares during the quarter. Tower […]
Tower Research Capital LLC TRC boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 208.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 201,060 shares of the biopharmaceutical company’s stock after acquiring an additional 135,782 shares during the quarter. Tower […]